U.S. Reviews CBD Amid Pressure to Act Quickly

(Bloomberg) -- The U.S. Food and Drug Administration will hold its first public hearing Friday into how it should regulate CBD products, and it may end up limiting how much of the cannabis compound...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.